Clinical Trial Update: Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating extending the time window for tenecteplase in patients with large vessel occlusion ischemic stroke has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: University of Melbourne | Conditions: Ischemic Stroke | Phase 3 | Status: TERMINATED